MiNK Therapeutics, Inc. Common Stock
Symbol: INKT (NASDAQ)
14.21
▼ (-0.91%) -0.130
Company Description:
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
Key Stats
- Today's Open: $14.7
- Today's High: $15.142
- Today's Low: $13.502
- Today's Volume: 44.25K
- Yesterday Close: $14.34
- Yesterday High: $15.3747
- Yesterday Low: $14.32
- Yesterday Volume: 24.84K
- Last Min Volume: 10
- Last Min High: $14.21
- Last Min Low: $14.21
- Last Min VWAP: $14.21
Company Profile
- Name: MiNK Therapeutics, Inc. Common Stock
- Website: https://www.minktherapeutics.com
- Listed Date: 2021-10-15
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001840229
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $64.86M
- Round Lot: 100
- Outstanding Shares: 4.52M
- Asset Type: CS
RECENT FILINGS FOR INKT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-22 | 424B5 | View |
| 2025-08-14 | S-8 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-07-15 | 424B5 | View |
| 2025-07-14 | 8-K | View |
| 2025-06-18 | 8-K | View |
Latest News on INKT